Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026)
Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
2,767.25% |
| Date | Value |
|---|
| Mar 31, 2026 |
2,767.25% |
| Dec 31, 2025 |
10.04% |
| Sep 30, 2025 |
475.28% |
| Jun 30, 2025 |
422.55% |
| Mar 31, 2025 |
201.63% |
| Dec 31, 2024 |
190.91% |
| Sep 30, 2024 |
181.91% |
| Jun 30, 2024 |
225.88% |
| Mar 31, 2024 |
295.12% |
| Dec 31, 2023 |
277.47% |
| Mar 31, 2023 |
-84.99% |
| Dec 31, 2022 |
287.65% |
| Sep 30, 2022 |
-28.48% |
| Jun 30, 2022 |
-23.82% |
| Mar 31, 2022 |
34.02% |
| Dec 31, 2021 |
35.95% |
| Sep 30, 2021 |
62.34% |
| Jun 30, 2021 |
32.96% |
| Mar 31, 2021 |
5.53% |
| Dec 31, 2020 |
16.20% |
